5 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18572399 | ERK1/2 AND KRAS G12C INHIBITORS COMBINATION THERAPY | ANDERSON, REBECCA L | 1626 | Non-Final OA | Dec 20, 2023 |
| 18572412 | SHP2 AND CDK4/6 INHIBITORS COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | KUCKLA, ANNA GRACE | 1626 | Non-Final OA | Dec 20, 2023 |
| 18256089 | COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | DAHLIN, HEATHER RAQUEL | 1629 | Non-Final OA | Jun 06, 2023 |
| 18256091 | COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | BURKETT, DANIEL JOHN | 1624 | Non-Final OA | Jun 06, 2023 |
| 18027313 | COMPOSITIONS AND METHODS FOR TREATING CANCER | BURKETT, DANIEL JOHN | 1624 | Final Rejection | Mar 20, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial